![[Dehydro-Pro4] Substance P (4-11)](https://file.medchemexpress.com/product_pic/hy-p3820.gif "Click to View [Dehydro-Pro4] Substance P (4-11) Product Detail")
Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
11 Results for "
dehydropeptidase
" in MedChemExpress (MCE) Product Catalog:
Products (11)
11 Results for "dehydropeptidase" in MCE Product Catalog:
7
Target:
Research Areas:
Cilastatin (MK0791) is a reversible, competitive renal dehydropeptidase I inhibitor with an IC50 of 0.1 μM. Cilastatin inhibits the bacterial metallob-lactamase enzyme CphA with an IC50 of 178 μM. Cilastatin is an antibacterial adjunct .
7
Target:
Research Areas:
Cilastatin sodium (MK0791 sodium) is a reversible, competitive renal dehydropeptidase I inhibitor with an IC50 of 0.1 μM. Cilastatin sodium inhibits the bacterial metallob-lactamase enzyme CphA with an IC50 of 178 μM. Cilastatin sodium is an antibacterial adjunct .
Cat. No.: HY-W561907
CAS No.: 85960-17-4
Target:
Research Areas:
IMipenem and cilastatin sodium is a broad-spectrum Carbapenem Antibiotic combination. Imipenem (HY-B1369A) is a Carbapenem antibiotic. IMipenem demonstrates excellent activity against gram-positive and gram-negative aerobic and anaerobic organisms. Cilastatin (HY-A0166) is a renal Dehydropeptidase inhibitor that inhibits the metabolism of Imipenem by renal brush-border enzymes, thus increasing imipenem concentrations in urine .
Cat. No.: HY-P3820
Target:
Research Areas:
Cat. No.: HY-A0166S
CAS No.: 2738376-83-3
Synonyms: MK0791-15N,d3
Cat. No.: HY-A0166R
CAS No.: 82009-34-5
Synonyms: MK0791 (Standard)
Target:
Research Areas:
Cilastatin (Standard) is the analytical standard of Cilastatin. This product is intended for research and analytical applications. Cilastatin (MK0791) is a reversible, competitive renal dehydropeptidase I inhibitor with an IC50 of 0.1 μM. Cilastatin inhibits the bacterial metallob-lactamase enzyme CphA with an IC50 of 178 μM. Cilastatin is an antibacterial adjunct .
Cat. No.: HY-A0166AR
CAS No.: 81129-83-1
Synonyms: MK0791 sodium (Standard)
Target:
Research Areas:
Cilastatin (sodium) (Standard) is the analytical standard of Cilastatin (sodium). This product is intended for research and analytical applications. Cilastatin sodium (MK0791 sodium) is a reversible, competitive renal dehydropeptidase I inhibitor with an IC50 of 0.1 μM. Cilastatin sodium inhibits the bacterial metallob-lactamase enzyme CphA with an IC50 of 178 μM. Cilastatin sodium is an antibacterial adjunct[1][2][3].
Cat. No.: HY-111282
CAS No.: 85394-14-5
Target:
Research Areas:
MK-789 is a competitive reversible inhibitor of dehydropeptidase I (DHP-I). MK-789 competitively blocks the entry of N-formimidoylthienamycin into proximal tubular cells, thereby inhibiting its renal metabolism. MK-789 shifts the renal excretion pathway of N-formimidoylthienamycin to glomerular filtration only, increasing its urinary recovery rate and renal clearance. MK-789 is applicable to studies on renal metabolism and pharmacokinetics .
Cat. No.: HY-P81486A
Synonyms: DPEP1; MDP; RDP; Dipeptidase 1; dehydropeptidase-I; Microsomal dipeptidase; Renal dipeptidase
Cat. No.: HY-P70003
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: DPEP1; HRDP; Dipeptidase 1; MDP; Microsomal Dipeptidase; RDP; Dipeptidase 1 (Renal); Testicular Tissue Protein Li 57; dehydropeptidase-I; Dipeptidase; Renal Dipeptidase; MBD1; Beta-Lactamase
Species:
Human
Source:
HEK293
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
